Evolved by Nature vs Genentech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Activated Silk Biomaterial Platform for Textiles & Personal Care
Evolved by Nature has developed Activated Silk technology — a green chemistry platform using natural silk proteins as sustainable, high-performance ingredients for textiles, personal care, and medical applications; raised over $120M;
About
Evolved by Nature is a Medford, Massachusetts-based biotechnology company founded in 2013 by Gregory Altman and Benedetto Marelli. The company has developed Activated Silk — a liquid silk protein platform that processes natural silk into a water-soluble biopolymer that can be applied as a functional coating or ingredient across multiple industries. Activated Silk is derived from Bombyx mori silkworm cocoons through an aqueous (water-based) process that preserves the protein's native properties without toxic chemicals, yielding a material that is biodegradable, biocompatible, and shelf-stable.
Roche subsidiary and founding biotech; invented the biologics industry with recombinant DNA. Blockbuster oncology franchise includes Herceptin, Avastin, Rituxan, and Tecentriq.
About
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching the modern biotechnology industry. Acquired by Roche in 2009 for $46.8 billion, Genentech continues to operate with significant R&D autonomy as the US hub for Roche's pharmaceutical innovation.\n\nThe company is best known for pioneering cancer biologics, developing Herceptin (trastuzumab) for HER2-positive breast cancer, Avastin (bevacizumab) for multiple cancers, Rituxan (rituximab) for lymphoma, and Tecentriq (atezolizumab) for PD-L1 immunotherapy. Its discovery engine spans oncology, neuroscience, ophthalmology, and immunology with a robust early-stage pipeline leveraging AI-assisted target identification.\n\nGenentech generates tens of billions in annual revenue through Roche's Pharmaceuticals Division and remains one of the most productive biotech research sites in the world, consistently ranked among top employers in life sciences. The South San Francisco campus employs over 13,000 scientists, clinicians, and engineers, anchoring the Bay Area as a global biotech hub.
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Evolved by Nature vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.